Research and Development

AstraZeneca will not follow this year's emerging pharma trend towards mega-mergers and may instead look to smaller-scale deals, according to …

New initiatives to bolster collaboration between the NHS, academia and industry have come amid claims that the UK is losing …

GSK has acquired Stiefel, the world's largest independent dermatology company, in a deal valued up to $3.6 billion. The move …

The world's two biggest pharma companies are to join forces to develop and market new treatments for HIV.GlaxoSmithKline is a …

Merck has signed an agreement with Vancouver-based Cardiome Pharma to develop its new treatment for atrial fibrillation vernakalant.Merck will pay …

Johnson & Johnson's monoclonal antibody Simponi has been given regulatory approval in Canada.Simponi (golimumab) has been given the green light …

Covance has opened new clinical development offices in Chile and Peru, and expanded its operations in Argentina to help serve …

Helsinn Birex Pharmaceuticals is to invest 13 million euros in a new pilot-scale R&D facility in Ireland, to help it …

An FDA advisory committee has concluded that safety concerns mean that Seroquel XR should not be used to treat anxiety, …

Lilly and Daiichi Sankyo's blood-thinning drug Efient has been launched in the UK for heart attack patients, taking on blockbuster …

The Merck and Schering-Plough merger creates a new industry giant to challenge Pfizer in terms of its scale and annual …

Covance has expanded its presence in clinical pharmacology in Europe with the acquisition of Swiss Pharma Contract, a 50-bed clinical …

The current economic downturn is having a braking effect on the top 10 contract research organisations, but a new report …

Quintiles has completed its 400th clinical trial using Electronic Data Capture (EDC). In addition to starting its 400th EDC trial, …